EUROIMMUN Logo
Find
X

What are you looking for?

Filter for products in our complete portfolio

Product finder

Worldwide
X
EUROIMMUN worldwide

This website provides an overview of the business activities and products of EUROIMMUN AG worldwide. Not all products are registered and approved in all countries or regions. Please contact your country representative for product availability and information

EUROIMMUN branches

Choose your country

Europe

North America

South & Central America

Asia

Middle East & Africa

EUROIMMUN Logo

Well prepared for the cold season: A new RSV assay supplementing the EURORealTime product family

he cold season 2022 has left marks: Nearly two years ago, an extraordinarily severe RSV wave brought children’s hospitals and paediatric practices, as well as the parents of affected children to their ...

Covering all bases – our portfolio for rheumatology

Diagnostics of the different autoimmune-related rheumatic diseases pose a particular challenge to rheumatologists: They are confronted with at least 400 inflammatory joint, connective tissue or ...

Abstracts of the 16th Dresden Symposium on Autoantibodies

Achievements and Challenges in Research, Diagnostics and Therapy of Autoimmune Diseases
Abstract collection 2023

Microscopy with LED technology: The EUROStar series

Do you remember 2005?
It was the year of USB flash drives, Bluetooth headsets, digital cameras – and the EUROStar. The first EUROIMMUN microscope was designed to simplify microscopy and eliminate the ...

Let’s change the perspective together! — ChLIA for allergy diagnostics

In allergy diagnostics, chemiluminescence immunoassays (ChLIA) contribute to quick and precise identification of sensitisations to allergens. They allow specific determination of IgE antibodies in the ...

Novel cell-based assay for autoantibody detection in demyelination

A novel cell-based immunofluorescence assay (CBA) provides sensitive and specific detection of IgM antibodies against myelin-associated glycoprotein (MAG), as demonstrated in a study published in ...

Neurological symptoms: a diagnostic challenge

There is a huge variety of neurological diseases and it often takes specialists a long time to figure out the cause of a patient’s symptoms. Doctors regularly encounter patients with unspecific ...

Novel autoantibody against DAGLA discovered in cerebellitis

Diacylglycerol lipase alpha (DAGLA) has been identified as a novel autoantibody target in patients with rapid progressive cerebellar ataxia. The autoantibodies were characterised as part of a ...

Antibody testing reduces dengue vaccination risk

As the COVID-19 pandemic has recently demonstrated, vaccinations are one of the most important and effective preventive measures in medicine for the protection against an infectious disease. Dengue ...

Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings

Revvity’s EUROIMMUN business, a leading provider of high-quality in-vitro diagnostic products, and ALPCO-GeneProof, a global leader in molecular diagnostics, jointly announced a strategic partnership ...

Page 2 of 9.

Back to top